Champion PeptideTirzepatide
Ordered Tirzepatide from Champion Peptide? Mail in a sample (US only) and let us test it for free.
Test my supplyChampion Peptide's tirzepatide has a low-concern profile under the purity-focus method, with steady identity, purity and fill results. Caveat: modest depth and early batch-ID gaps; the newer test adds batch ID and endotoxins below LOQ.
Forum history predates the current CHP domain, while corporate wording shifts without a registry-grade counterparty. Shared hosting, template residue naming BCX/Xiang, rotating aliases, crypto rails, and an unverified US-warehouse claim complicate channel verification.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Champion Peptide rows.
Cancel anytime
About Champion Peptide test results from Finnrick
Champion Peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 4 peptides and 17 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Champion Peptide peptides in this dataset are GHK-Cu (2 tests), Ipamorelin (3 tests) and Retatrutide (8 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 17 recent tests.
Ordered Tirzepatide from Champion Peptide? Mail in a sample (US only) and let us test it for free.
Test my supply